glp-1 lilly FDA approves new weight-loss pill, Foundayo US approves new oral weight-loss

Fibre plays a key role in supporting gut health, promoting regular digestion, and helping you feel satisfied between meals

Article Summary: GLP1s and GIP dual agonists like Mounjaro and Wegovy are once-weekly injections prescribed for weight loss and type 2 diabetes

Licensed healthcare professionals evaluate each patient to determine eligibility and create personalized treatment plans focused on safe, sustainable weight loss and metabolic health

In recent years, GLP-1RAs, initially developed for treating T2DM, have gained increasing attention for their cardioprotective effectsparticularly in improving left ventricular function and reducing cardiovascular events

It would be of great interest to determine whether it is possible to stimulate, also in a clinical setting, specific GLP-1 populations

For patients with type 2 diabetes who maintained a stable weight, GLP-1 use was associated with an 8.7% lower osteoporosis risk compared to patients who did not use a GLP-1, as seen in Figure 1